definiens: shall mean the clinical study initiated by [COMPANY] prior to the Effective Date under Gilead’sclinical study protocol entitled “ A Phase 3, Randomized, Open - Label, Multicenter Study of the Treatment ofAntiretroviral - Naïve, HIV-1 - Infected Subjects comparing Tenofovir Disoproxil Fumarate and Emtricitabine inCombination with Efavirenz Versus Combivir ® ( lamivudine / zidovudine ) and Efavirenz ” ( as such protocol may berevised and such study may be extended or expanded from time to time, in each case by [COMPANY] ) . For the avoidanceof doubt, the conduct of Study 934 shall not be deemed a Development Activity or Project Activity for purposes ofthis Agreement, and Clinical Data derived or generated from Study 934 or from testing or analysis of subjects orsamples from Study 934 shall be [COMPANY] Know - How, not Joint Know - How